{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Week 4 - Word Embeddings Supplemental\n",
    "\n",
    "This notebook contains two additional uses for word embeddings\n",
    "\n",
    "For this notebook we will be using the following packages"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Special module written for this class\n",
    "#This provides access to data and to helper functions from previous weeks\n",
    "#Make sure you update it before starting this notebook\n",
    "import lucem_illud #pip install -U git+git://github.com/Computational-Content-Analysis-2018/lucem_illud.git\n",
    "\n",
    "#All these packages need to be installed from pip\n",
    "import gensim#For word2vec, etc\n",
    "import requests #For downloading our datasets\n",
    "import nltk #For stop words and stemmers\n",
    "import numpy as np #For arrays\n",
    "import pandas #Gives us DataFrames\n",
    "import matplotlib.pyplot as plt #For graphics\n",
    "import seaborn #Makes the graphics look nicer\n",
    "import sklearn.metrics.pairwise #For cosine similarity\n",
    "import sklearn.manifold #For T-SNE\n",
    "import sklearn.decomposition #For PCA\n",
    "import copy\n",
    "\n",
    "#gensim uses a couple of deprecated features\n",
    "#we can't do anything about them so lets ignore them \n",
    "import warnings\n",
    "warnings.filterwarnings(\"ignore\", category=DeprecationWarning) \n",
    "\n",
    "#This 'magic' command makes the plots work better\n",
    "#in the notebook, don't use it outside of a notebook.\n",
    "#Also you can ignore the warning\n",
    "%matplotlib inline\n",
    "\n",
    "import os #For looking through files\n",
    "import os.path #For managing file paths"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# The Score Function\n",
    "\n",
    "The score function is a simple calculation developed by [Matt Taddy](https://arxiv.org/pdf/1504.07295.pdf) to calculate the likelihood that a given text would have been generated by a word-embedding model by summing the inner product between each pair of the text's word vectors. \n",
    "\n",
    "Here, we explore this using a model trained with millions of resumes from the CareerBuilder website (we can't share the private resumes...but we can share a model built with them :-):"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "ename": "AttributeError",
     "evalue": "'Word2Vec' object has no attribute 'min_alpha_yet_reached'",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mAttributeError\u001b[0m                            Traceback (most recent call last)",
      "\u001b[0;32m~/.local/lib/python3.6/site-packages/gensim/models/word2vec.py\u001b[0m in \u001b[0;36mload\u001b[0;34m(cls, *args, **kwargs)\u001b[0m\n\u001b[1;32m    974\u001b[0m         \u001b[0;32mtry\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 975\u001b[0;31m             \u001b[0;32mreturn\u001b[0m \u001b[0msuper\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mWord2Vec\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mcls\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mload\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    976\u001b[0m         \u001b[0;32mexcept\u001b[0m \u001b[0mAttributeError\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;32m~/.local/lib/python3.6/site-packages/gensim/models/base_any2vec.py\u001b[0m in \u001b[0;36mload\u001b[0;34m(cls, *args, **kwargs)\u001b[0m\n\u001b[1;32m    628\u001b[0m     \u001b[0;32mdef\u001b[0m \u001b[0mload\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mcls\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 629\u001b[0;31m         \u001b[0mmodel\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0msuper\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mBaseWordEmbeddingsModel\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mcls\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mload\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    630\u001b[0m         \u001b[0;32mif\u001b[0m \u001b[0mmodel\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mnegative\u001b[0m \u001b[0;32mand\u001b[0m \u001b[0mhasattr\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mmodel\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mwv\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m'index2word'\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;32m~/.local/lib/python3.6/site-packages/gensim/models/base_any2vec.py\u001b[0m in \u001b[0;36mload\u001b[0;34m(cls, fname_or_handle, **kwargs)\u001b[0m\n\u001b[1;32m    277\u001b[0m     \u001b[0;32mdef\u001b[0m \u001b[0mload\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mcls\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mfname_or_handle\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 278\u001b[0;31m         \u001b[0;32mreturn\u001b[0m \u001b[0msuper\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mBaseAny2VecModel\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mcls\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mload\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mfname_or_handle\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    279\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;32m~/.local/lib/python3.6/site-packages/gensim/utils.py\u001b[0m in \u001b[0;36mload\u001b[0;34m(cls, fname, mmap)\u001b[0m\n\u001b[1;32m    395\u001b[0m         \u001b[0mobj\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0munpickle\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mfname\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 396\u001b[0;31m         \u001b[0mobj\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_load_specials\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mfname\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mmmap\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mcompress\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0msubname\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    397\u001b[0m         \u001b[0mlogger\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0minfo\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"loaded %s\"\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mfname\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;32m~/.local/lib/python3.6/site-packages/gensim/utils.py\u001b[0m in \u001b[0;36m_load_specials\u001b[0;34m(self, fname, mmap, compress, subname)\u001b[0m\n\u001b[1;32m    438\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 439\u001b[0;31m             \u001b[0msetattr\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mattrib\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mval\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    440\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;32m~/.local/lib/python3.6/site-packages/gensim/utils.py\u001b[0m in \u001b[0;36mnew_func1\u001b[0;34m(*args, **kwargs)\u001b[0m\n\u001b[1;32m   1367\u001b[0m                 )\n\u001b[0;32m-> 1368\u001b[0;31m                 \u001b[0;32mreturn\u001b[0m \u001b[0mfunc\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1369\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;32m~/.local/lib/python3.6/site-packages/gensim/models/base_any2vec.py\u001b[0m in \u001b[0;36msyn1\u001b[0;34m(self, value)\u001b[0m\n\u001b[1;32m    364\u001b[0m     \u001b[0;32mdef\u001b[0m \u001b[0msyn1\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mvalue\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 365\u001b[0;31m         \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mtrainables\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0msyn1\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mvalue\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    366\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;31mAttributeError\u001b[0m: 'Word2Vec' object has no attribute 'trainables'",
      "\nDuring handling of the above exception, another exception occurred:\n",
      "\u001b[0;31mAttributeError\u001b[0m                            Traceback (most recent call last)",
      "\u001b[0;32m<ipython-input-4-7cd432b43847>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m()\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0mresume_model\u001b[0m  \u001b[0;34m=\u001b[0m \u001b[0mgensim\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mmodels\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mword2vec\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mWord2Vec\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mload\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m'../4-Word-Embedding/resumeAll.model'\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[0;32m~/.local/lib/python3.6/site-packages/gensim/models/word2vec.py\u001b[0m in \u001b[0;36mload\u001b[0;34m(cls, *args, **kwargs)\u001b[0m\n\u001b[1;32m    977\u001b[0m             \u001b[0mlogger\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0minfo\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m'Model saved using code from earlier Gensim Version. Re-loading old model in a compatible way.'\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    978\u001b[0m             \u001b[0;32mfrom\u001b[0m \u001b[0mgensim\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mmodels\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdeprecated\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mword2vec\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mload_old_word2vec\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 979\u001b[0;31m             \u001b[0;32mreturn\u001b[0m \u001b[0mload_old_word2vec\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    980\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    981\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;32m~/.local/lib/python3.6/site-packages/gensim/models/deprecated/word2vec.py\u001b[0m in \u001b[0;36mload_old_word2vec\u001b[0;34m(*args, **kwargs)\u001b[0m\n\u001b[1;32m    193\u001b[0m     \u001b[0mnew_model\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mrunning_training_loss\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mold_model\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m__dict__\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mget\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m'running_training_loss'\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    194\u001b[0m     \u001b[0mnew_model\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mtotal_train_time\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mold_model\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mtotal_train_time\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 195\u001b[0;31m     \u001b[0mnew_model\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mmin_alpha_yet_reached\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mold_model\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mmin_alpha_yet_reached\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    196\u001b[0m     \u001b[0mnew_model\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mmodel_trimmed_post_training\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mold_model\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m__dict__\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mget\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m'model_trimmed_post_training'\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    197\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;31mAttributeError\u001b[0m: 'Word2Vec' object has no attribute 'min_alpha_yet_reached'"
     ]
    }
   ],
   "source": [
    "resume_model  = gensim.models.word2vec.Word2Vec.load('../4-Word-Embedding/resumeAll.model')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We can examine the vacabularies of this model by building a word-index map:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "vocab = resume_model.index2word"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Let's just load the sample and take a look at it. The sentences in each job description are already tokenized and normalized."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "sampleDF = pandas.read_csv('../data/SampleJobAds.csv', index_col = False)\n",
    "#We need to convert the last couple columns from strings to lists\n",
    "sampleDF['tokenized_sents'] = sampleDF['tokenized_sents'].apply(lambda x: eval(x))\n",
    "sampleDF['normalized_sents'] = sampleDF['normalized_sents'].apply(lambda x: eval(x))\n",
    "sampleDF"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Let's define a function to calculate the likelihood of each job description. The idea is borrowed from [Matt Taddy](https://github.com/RaRe-Technologies/gensim/blob/develop/docs/notebooks/deepir.ipynb), who shows how a document can be characterized as the inner product of the distance between its words. In other words, this analysis will show which job ads are most likely to find an appropriate pool of workers in the resume bank that generated our word embedding.  "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "def adprob(ad, model):\n",
    "    sen_scores = model.score(ad, len(ad))\n",
    "    ad_score = sen_scores.mean()\n",
    "    return ad_score"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Let's apply this function to every job description."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "sampleDF['likelihood'] = sampleDF['normalized_sents'].apply(lambda x: adprob(x, resume_model))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Let's take a look at the top 5 job descriptions that have the highest likelihood."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "for ad in sampleDF.sort_values(by = 'likelihood', ascending = False)['jobDescription'][:5]:\n",
    "    print (ad + '\\n\\n')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Let's take a look at the bottom 5 job descriptions that have the lowest likelihood to be matched by the resumes."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "for ad in sampleDF.sort_values(by = 'likelihood')['jobDescription'][:5]:\n",
    "    print (ad + '\\n\\n')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We can do the same for phrases corresponding to job skills."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "adprob([[\"python\", \"programming\"]], resume_model)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "adprob([[\"basic\", \"programming\"]], resume_model)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Basic programming appears to be more likely in this pool of resumes than python programming. "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We can also do some simple statistics. Unfortunately, we don't have a large sample here. Nevertheless, let's first look at the mean likelihood score of each hiring organization. Some organizations will do well to hire on CareerBuilder...while others will not."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "sampleDF.groupby(\"hiringOrganization_organizationName\")[['likelihood']].mean().sort_values('likelihood', ascending = False)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We can also look at the mean likelihood of each state."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "sampleDF.groupby(\"jobLocation_address_region\")[['likelihood']].mean().sort_values('likelihood', ascending = False)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "You would increase the sample size if you want to do a more serious study."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## <span style=\"color:red\">*Exercise 1a*</span>\n",
    "\n",
    "<span style=\"color:red\">**Do only 1a or 1b.** Construct cells immediately below this that calculate the scores for a small sample of documents from outside your corpus to identify which are *closest* to your corpus. Then calculate the scores for a few phrases or sentences to identify the ones most likely to have appeared in your corpus. Interrogate patterns associated with these document/phrase scores (e.g., which companies produced job ads most or least likely to find jobseekers in the resume corpus?) What do these patterns suggest about the boundaries of your corpus?"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Linguistic Change"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Below is code that aligns the dimensions of multiple embeddings arrayed over time or some other dimension and allow identification of semantic chanage as the word vectors change their loadings for focal words. This code comes from the approach piloted at Stanford by William Hamilton, Daniel Jurafsky and Jure Lescovec [here](https://arxiv.org/pdf/1605.09096.pdf). "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "def calc_syn0norm(model):\n",
    "    \"\"\"since syn0norm is now depricated\"\"\"\n",
    "    return (model.wv.syn0 / np.sqrt((model.wv.syn0 ** 2).sum(-1))[..., np.newaxis]).astype(np.float32)\n",
    "\n",
    "def smart_procrustes_align_gensim(base_embed, other_embed, words=None):\n",
    "    \"\"\"Procrustes align two gensim word2vec models (to allow for comparison between same word across models).\n",
    "    Code ported from HistWords <https://github.com/williamleif/histwords> by William Hamilton <wleif@stanford.edu>.\n",
    "    (With help from William. Thank you!)\n",
    "    First, intersect the vocabularies (see `intersection_align_gensim` documentation).\n",
    "    Then do the alignment on the other_embed model.\n",
    "    Replace the other_embed model's syn0 and syn0norm numpy matrices with the aligned version.\n",
    "    Return other_embed.\n",
    "    If `words` is set, intersect the two models' vocabulary with the vocabulary in words (see `intersection_align_gensim` documentation).\n",
    "    \"\"\"\n",
    "    base_embed = copy.copy(base_embed)\n",
    "    other_embed = copy.copy(other_embed)\n",
    "    # make sure vocabulary and indices are aligned\n",
    "    in_base_embed, in_other_embed = intersection_align_gensim(base_embed, other_embed, words=words)\n",
    "\n",
    "    # get the embedding matrices\n",
    "    base_vecs = calc_syn0norm(in_base_embed)\n",
    "    other_vecs = calc_syn0norm(in_other_embed)\n",
    "\n",
    "    # just a matrix dot product with numpy\n",
    "    m = other_vecs.T.dot(base_vecs) \n",
    "    # SVD method from numpy\n",
    "    u, _, v = np.linalg.svd(m)\n",
    "    # another matrix operation\n",
    "    ortho = u.dot(v) \n",
    "    # Replace original array with modified one\n",
    "    # i.e. multiplying the embedding matrix (syn0norm)by \"ortho\"\n",
    "    other_embed.wv.syn0norm = other_embed.wv.syn0 = (calc_syn0norm(other_embed)).dot(ortho)\n",
    "    return other_embed\n",
    "    \n",
    "def intersection_align_gensim(m1,m2, words=None):\n",
    "    \"\"\"\n",
    "    Intersect two gensim word2vec models, m1 and m2.\n",
    "    Only the shared vocabulary between them is kept.\n",
    "    If 'words' is set (as list or set), then the vocabulary is intersected with this list as well.\n",
    "    Indices are re-organized from 0..N in order of descending frequency (=sum of counts from both m1 and m2).\n",
    "    These indices correspond to the new syn0 and syn0norm objects in both gensim models:\n",
    "        -- so that Row 0 of m1.syn0 will be for the same word as Row 0 of m2.syn0\n",
    "        -- you can find the index of any word on the .index2word list: model.index2word.index(word) => 2\n",
    "    The .vocab dictionary is also updated for each model, preserving the count but updating the index.\n",
    "    \"\"\"\n",
    "\n",
    "    # Get the vocab for each model\n",
    "    vocab_m1 = set(m1.wv.vocab.keys())\n",
    "    vocab_m2 = set(m2.wv.vocab.keys())\n",
    "\n",
    "    # Find the common vocabulary\n",
    "    common_vocab = vocab_m1&vocab_m2\n",
    "    if words: common_vocab&=set(words)\n",
    "\n",
    "    # If no alignment necessary because vocab is identical...\n",
    "    if not vocab_m1-common_vocab and not vocab_m2-common_vocab:\n",
    "        return (m1,m2)\n",
    "\n",
    "    # Otherwise sort by frequency (summed for both)\n",
    "    common_vocab = list(common_vocab)\n",
    "    common_vocab.sort(key=lambda w: m1.wv.vocab[w].count + m2.wv.vocab[w].count,reverse=True)\n",
    "\n",
    "    # Then for each model...\n",
    "    for m in [m1,m2]:\n",
    "        # Replace old syn0norm array with new one (with common vocab)\n",
    "        indices = [m.wv.vocab[w].index for w in common_vocab]\n",
    "        old_arr = calc_syn0norm(m)\n",
    "        new_arr = np.array([old_arr[index] for index in indices])\n",
    "        m.wv.syn0norm = m.wv.syn0 = new_arr\n",
    "\n",
    "        # Replace old vocab dictionary with new one (with common vocab)\n",
    "        # and old index2word with new one\n",
    "        m.index2word = common_vocab\n",
    "        old_vocab = m.wv.vocab\n",
    "        new_vocab = {}\n",
    "        for new_index,word in enumerate(common_vocab):\n",
    "            old_vocab_obj=old_vocab[word]\n",
    "            new_vocab[word] = gensim.models.word2vec.Vocab(index=new_index, count=old_vocab_obj.count)\n",
    "        m.wv.vocab = new_vocab\n",
    "\n",
    "    return (m1,m2)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "In order to explore this, let's get some data that follows a time trend. We'll look at conference proceedings from the American Society for Clinical Oncologists."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "ascoDF = pandas.read_csv(\"../4-Word-Embedding/ASCO_abstracts.csv\", index_col=0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Year</th>\n",
       "      <th>AbstractCategory</th>\n",
       "      <th>Title</th>\n",
       "      <th>FirstAuthor</th>\n",
       "      <th>Body</th>\n",
       "      <th>AbstractPublicationID</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1995</td>\n",
       "      <td>Lung Cancer</td>\n",
       "      <td>Treatment of non-small cell lung cancer with c...</td>\n",
       "      <td>GP Stathopoulos</td>\n",
       "      <td>Cisplatin compound is established as the main ...</td>\n",
       "      <td>1181</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1995</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Treatment of primary breast cancer without mas...</td>\n",
       "      <td>A Bluming</td>\n",
       "      <td>Between March 24, 1977, and March 24, 1983, 15...</td>\n",
       "      <td>270</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1995</td>\n",
       "      <td>Gynecologic Cancer</td>\n",
       "      <td>Treatment of relapsed ovarian carcinoma with e...</td>\n",
       "      <td>M Metzner</td>\n",
       "      <td>ECF has established activity and a high respon...</td>\n",
       "      <td>784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1995</td>\n",
       "      <td>Lung Cancer</td>\n",
       "      <td>Treatment of small cell lung cancer (SCLC) wit...</td>\n",
       "      <td>JD Hainsworth</td>\n",
       "      <td>In 7/93, we began investigation of a three-dru...</td>\n",
       "      <td>1197</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1995</td>\n",
       "      <td>Other Gastrointestinal Cancer</td>\n",
       "      <td>Vaccine-based (active specific) chemoimmunothe...</td>\n",
       "      <td>SH Itzkowitz</td>\n",
       "      <td>Active specific immunotherapy (ASI) is the adm...</td>\n",
       "      <td>549</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>1995</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Validation of a model that identifies high ris...</td>\n",
       "      <td>GM Clark</td>\n",
       "      <td>Breast cancer patients with 10 or more positiv...</td>\n",
       "      <td>69</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>1995</td>\n",
       "      <td>Genitourinary Cancer</td>\n",
       "      <td>Validation of the PROSQOLI: a pragmatic outcom...</td>\n",
       "      <td>M Stockler</td>\n",
       "      <td>Rationale: Traditional outcome measures are un...</td>\n",
       "      <td>649</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>1995</td>\n",
       "      <td>Preclinical Experimental Therapeutics - Other</td>\n",
       "      <td>'In vitro' comparative assay on fluorouracil (...</td>\n",
       "      <td>A Abad</td>\n",
       "      <td>The clinical experience with biochemical modul...</td>\n",
       "      <td>1609</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>1995</td>\n",
       "      <td>Tumor Biology</td>\n",
       "      <td>'Medical cultural diversity' among medical onc...</td>\n",
       "      <td>R Hochman</td>\n",
       "      <td>Most MO rely on prospective randomized trials....</td>\n",
       "      <td>1633</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>1995</td>\n",
       "      <td>Developmental TherapeuticsÑClinical Pharmacolo...</td>\n",
       "      <td>13-cis-retinoic acid plus low dose recombinant...</td>\n",
       "      <td>GM Turola</td>\n",
       "      <td>Both interferons and retinoids are known to po...</td>\n",
       "      <td>709</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>1995</td>\n",
       "      <td>Hematologic MalignanciesÑLymphoma and Chronic ...</td>\n",
       "      <td>2-Chlorodeoxyadenosine (2-CDA) leads to partia...</td>\n",
       "      <td>T Lippuner</td>\n",
       "      <td>The prognosis of AILD, a rare low grade T-cell...</td>\n",
       "      <td>1273</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>1995</td>\n",
       "      <td>Hematologic MalignanciesÑLymphoma and Chronic ...</td>\n",
       "      <td>23-year follow-up after radiotherapy (RT) or r...</td>\n",
       "      <td>PH Wiernik</td>\n",
       "      <td>75 patients (pts) with HD pathologic stages IA...</td>\n",
       "      <td>1285</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>1995</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>15 years follow-up for T4d (inflammatory) brea...</td>\n",
       "      <td>F Morvan</td>\n",
       "      <td>From 1979 to 1984, 71 patients with UICC T4d i...</td>\n",
       "      <td>265</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>1995</td>\n",
       "      <td>Hematologic MalignanciesÑLeukemia, Myelodyspla...</td>\n",
       "      <td>2-CDA +/- ara-C is ineffective therapy for rel...</td>\n",
       "      <td>S Kornblau</td>\n",
       "      <td>Santana et al reported a CR rate of 8/17 (95% ...</td>\n",
       "      <td>1005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>1995</td>\n",
       "      <td>Hematologic MalignanciesÑLeukemia, Myelodyspla...</td>\n",
       "      <td>2-chlorodeoxyadenosine (2-CdA) in the treatmen...</td>\n",
       "      <td>M Tallman</td>\n",
       "      <td>Since human monocyte cell lines show in vitro ...</td>\n",
       "      <td>1022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>1995</td>\n",
       "      <td>Developmental TherapeuticsÑClinical Pharmacolo...</td>\n",
       "      <td>3 versus 6 versus 24 hour infusions of paclita...</td>\n",
       "      <td>D Rischin</td>\n",
       "      <td>The infusion duration of paclitaxel has varied...</td>\n",
       "      <td>1500</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>1995</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>3-hr high-dose taxol (T) infusion following st...</td>\n",
       "      <td>E Mamounas</td>\n",
       "      <td>T has shown significant antitumor activity in ...</td>\n",
       "      <td>207</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>1995</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>3-hr high-dose taxol (T) infusion in advanced ...</td>\n",
       "      <td>E Mamounas</td>\n",
       "      <td>High-dose T has shown significant antitumor ac...</td>\n",
       "      <td>206</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>1995</td>\n",
       "      <td>Central Nervous System Tumors</td>\n",
       "      <td>3H-paclitaxel (3H-P) tissue concentrations wit...</td>\n",
       "      <td>GJ Lesser</td>\n",
       "      <td>Ongoing clinical trials are evaluating the eff...</td>\n",
       "      <td>292</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>1995</td>\n",
       "      <td>Other Gastrointestinal Cancer</td>\n",
       "      <td>5 fluorouracil (5Fu), mitomycin-C, leucovorin ...</td>\n",
       "      <td>GS Soori</td>\n",
       "      <td>Between 1991 and 1994, 28 patients with gastro...</td>\n",
       "      <td>575</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>1995</td>\n",
       "      <td>Developmental TherapeuticsÑClinical Pharmacolo...</td>\n",
       "      <td>5-Ethynyluracil (776C85), an inhibitor of dihy...</td>\n",
       "      <td>AA Adjei</td>\n",
       "      <td>The erratic bioavailability (BA) of oral 5-FU ...</td>\n",
       "      <td>1478</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>1995</td>\n",
       "      <td>Other Gastrointestinal Cancer</td>\n",
       "      <td>5-fluorouracil (5FU) + levamisole (LEVA) vs 5F...</td>\n",
       "      <td>P Bruzzi</td>\n",
       "      <td>To determine whether the addition of 6-S-LV to...</td>\n",
       "      <td>497</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>1995</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>5-Year results of high-dose sequential (HDS) a...</td>\n",
       "      <td>AM Gianni</td>\n",
       "      <td>To improve the results of adjuvant chemotherap...</td>\n",
       "      <td>61</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>1995</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>96-hour paclitaxel after prior short taxane in...</td>\n",
       "      <td>AD Seidman</td>\n",
       "      <td>Paclitaxel (P) via 96 hr infusion has signific...</td>\n",
       "      <td>151</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>1995</td>\n",
       "      <td>Developmental TherapeuticsÑClinical Pharmacolo...</td>\n",
       "      <td>96-hour paclitaxel without and with R-verapami...</td>\n",
       "      <td>D Riseberg</td>\n",
       "      <td>We conducted a two part trial of 96-hr infusio...</td>\n",
       "      <td>403</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>1995</td>\n",
       "      <td>Sarcoma</td>\n",
       "      <td>A Canadian national tumor bank/data base for s...</td>\n",
       "      <td>V Bramwell</td>\n",
       "      <td>A network established by a cooperative clinica...</td>\n",
       "      <td>1694</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>1995</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>A Canadian perspective on breast conservative ...</td>\n",
       "      <td>C Kotwall</td>\n",
       "      <td>Between 5/88 and 6/93, 220 consecutive women w...</td>\n",
       "      <td>249</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>1995</td>\n",
       "      <td>Developmental TherapeuticsÑClinical Pharmacolo...</td>\n",
       "      <td>A clinical evaluation of Duragesic (transderma...</td>\n",
       "      <td>J Gardner-Nix</td>\n",
       "      <td>Between May 1992 and April 1994, 250 patients ...</td>\n",
       "      <td>390</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>1995</td>\n",
       "      <td>Psychosocial Aspects of Cancer</td>\n",
       "      <td>A comparison of two quality-of-life (QOL) ques...</td>\n",
       "      <td>MT King</td>\n",
       "      <td>FLIC and QLQ-C30 were administered concurrentl...</td>\n",
       "      <td>1651</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>1995</td>\n",
       "      <td>Health Care Research</td>\n",
       "      <td>A comprehensive analysis of the cost basis of ...</td>\n",
       "      <td>F Khuri</td>\n",
       "      <td>We have carried out a comprehensive database a...</td>\n",
       "      <td>905</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62348</th>\n",
       "      <td>2011</td>\n",
       "      <td>Gastrointestinal (Colorectal) Cancer</td>\n",
       "      <td>Bevacizumab plus capecitabine as maintenance t...</td>\n",
       "      <td>S. Yalcin</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; Colorectal cancer is one...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62351</th>\n",
       "      <td>2011</td>\n",
       "      <td>Health Services Research</td>\n",
       "      <td>The relationship between cost, quality, and ou...</td>\n",
       "      <td>M. J. Hassett</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; Breast cancer (BrCa) is ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62361</th>\n",
       "      <td>2011</td>\n",
       "      <td>Patient and Survivor Care</td>\n",
       "      <td>Effect of Medical Qigong on cognitive function...</td>\n",
       "      <td>B. Oh</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background: &lt;/b&gt;   Cancer patients often...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62362</th>\n",
       "      <td>2011</td>\n",
       "      <td>Developmental TherapeuticsÑClinical Pharmacolo...</td>\n",
       "      <td>Tumor-targeted cancer vaccination (GeneVieve P...</td>\n",
       "      <td>J. G. Ignacio</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; Rexin-G and Reximmune-C ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62371</th>\n",
       "      <td>2011</td>\n",
       "      <td>Hematologic MalignanciesÑLeukemia, Myelodyspla...</td>\n",
       "      <td>Activity and tolerability of the Bruton&amp;#39;s ...</td>\n",
       "      <td>J. C. Byrd</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background: &lt;/b&gt;  Btk is essential to B-...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62386</th>\n",
       "      <td>2011</td>\n",
       "      <td>Breast CancerÑTriple-Negative/Cytotoxics/Local...</td>\n",
       "      <td>Lymphocyte infiltration (LI) and immunohistoch...</td>\n",
       "      <td>C. S. Yau</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; IHC is a readily availab...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62396</th>\n",
       "      <td>2011</td>\n",
       "      <td>Gastrointestinal (Colorectal) Cancer</td>\n",
       "      <td>Role of routine adjuvant chemotherapy after ne...</td>\n",
       "      <td>R. P. Kiran</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; The current standard of ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62402</th>\n",
       "      <td>2011</td>\n",
       "      <td>Developmental TherapeuticsÑClinical Pharmacolo...</td>\n",
       "      <td>A novel approach to rituximab biosimilar drug ...</td>\n",
       "      <td>S. M. Berry</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt;  Regulatory uncertainty ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62407</th>\n",
       "      <td>2011</td>\n",
       "      <td>Hematologic MalignanciesÑLymphoma and Chronic ...</td>\n",
       "      <td>Long-term safety of lenalidomide (LEN) in rela...</td>\n",
       "      <td>B. G. Durie</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; LEN has significantly ex...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62414</th>\n",
       "      <td>2011</td>\n",
       "      <td>Genitourinary Cancer</td>\n",
       "      <td>Multisolution variance-based optimization (MVB...</td>\n",
       "      <td>M. A. Laviraj</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; Oncentra Prostate real-t...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62431</th>\n",
       "      <td>2011</td>\n",
       "      <td>Cancer Prevention/Epidemiology</td>\n",
       "      <td>The impact of screening mammography in breast ...</td>\n",
       "      <td>C. Checka</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; Recent recommendations b...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62452</th>\n",
       "      <td>2011</td>\n",
       "      <td>Cancer Prevention/Epidemiology</td>\n",
       "      <td>Body mass index: A potential risk factor for b...</td>\n",
       "      <td>V. Sharma</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; Breast cancer (BC), the ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62456</th>\n",
       "      <td>2011</td>\n",
       "      <td>Melanoma/Skin Cancers</td>\n",
       "      <td>Frequency of mutations associated with targete...</td>\n",
       "      <td>S. Cheng</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; &lt;i&gt;BRAF&lt;/i&gt;,&lt;i&gt; RAS&lt;/i&gt;,...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62462</th>\n",
       "      <td>2011</td>\n",
       "      <td>Health Services Research</td>\n",
       "      <td>Rapid improvement in evidence-based, quality c...</td>\n",
       "      <td>M. A. Amin</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; ASCO&amp;#39;s Quality Oncol...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62467</th>\n",
       "      <td>2011</td>\n",
       "      <td>Central Nervous System Tumors</td>\n",
       "      <td>FLT-PET analysis of early response to everolim...</td>\n",
       "      <td>J. N. Sarkaria</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; 18F-fluorodeoxyuridine (...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62484</th>\n",
       "      <td>2011</td>\n",
       "      <td>Central Nervous System Tumors</td>\n",
       "      <td>Prognostic factors in elderly patients with gr...</td>\n",
       "      <td>A. Satra</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; Anaplastic astrocytoma (...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62503</th>\n",
       "      <td>2011</td>\n",
       "      <td>Health Services Research</td>\n",
       "      <td>Changes in global patterns of care for first-l...</td>\n",
       "      <td>A. J. Combest</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; Few reports have focused...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62512</th>\n",
       "      <td>2011</td>\n",
       "      <td>Health Services Research</td>\n",
       "      <td>Time to publication of the results of clinical...</td>\n",
       "      <td>H. Katayama</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; It was previously report...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62515</th>\n",
       "      <td>2011</td>\n",
       "      <td>Developmental TherapeuticsÑExperimental Therap...</td>\n",
       "      <td>Treatment (Tx) guidelines for skin and mucosal...</td>\n",
       "      <td>M. J. Borad</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; TH&amp;#8209;302 is essentia...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62541</th>\n",
       "      <td>2011</td>\n",
       "      <td>Health Services Research</td>\n",
       "      <td>Barriers to implementing primary HER2 FISH tes...</td>\n",
       "      <td>G. J. Tsongalis</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; Two HER2/neu testing pro...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62543</th>\n",
       "      <td>2011</td>\n",
       "      <td>Patient and Survivor Care</td>\n",
       "      <td>Understanding causes for distress among cancer...</td>\n",
       "      <td>S. A. Taylor</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; While both cancer diagno...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62544</th>\n",
       "      <td>2011</td>\n",
       "      <td>Tumor Biology</td>\n",
       "      <td>Fluorodeoxiglucose (FDG)-avidity at positron e...</td>\n",
       "      <td>S. Redana</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; Reduced FDG avidity in m...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62551</th>\n",
       "      <td>2011</td>\n",
       "      <td>Health Services Research</td>\n",
       "      <td>Impact of travel distance on early diagnosis o...</td>\n",
       "      <td>J. A. Holmes</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; Patients with an elevate...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62561</th>\n",
       "      <td>2011</td>\n",
       "      <td>Developmental TherapeuticsÑExperimental Therap...</td>\n",
       "      <td>Poly(ADP ribose) polymerase (PARP) inhibition ...</td>\n",
       "      <td>D. R. Shalinsky</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; PARP activity in PBLs or...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62564</th>\n",
       "      <td>2011</td>\n",
       "      <td>Pediatric Oncology</td>\n",
       "      <td>A phase I study of ifosfamide, oxaliplatin, an...</td>\n",
       "      <td>L. M. McGregor</td>\n",
       "      <td>&lt;p&gt; &lt;b&gt;Background:&lt;/b&gt; Carboplatin and cisplat...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62568</th>\n",
       "      <td>2011</td>\n",
       "      <td>Lung Cancer - Local-Regional and Adjuvant Ther...</td>\n",
       "      <td>Management of thymic epithelial tumors (TETs) ...</td>\n",
       "      <td>A. Rajan</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background: &lt;/b&gt; TETs are very rare ante...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62576</th>\n",
       "      <td>2011</td>\n",
       "      <td>Patient and Survivor Care</td>\n",
       "      <td>Spinal or epidural analgesia for cancer pain: ...</td>\n",
       "      <td>N. Yarom</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; Cancer pain is occasiona...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62577</th>\n",
       "      <td>2011</td>\n",
       "      <td>Developmental TherapeuticsÑExperimental Therap...</td>\n",
       "      <td>Comparative PARP enzyme inhibition of PF-01367...</td>\n",
       "      <td>K. A. Kern</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; Within the past several ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62585</th>\n",
       "      <td>2011</td>\n",
       "      <td>Genitourinary Cancer</td>\n",
       "      <td>Risk stratification and stage migration effect...</td>\n",
       "      <td>B. B. Desai</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; To evaluate the diagnost...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62604</th>\n",
       "      <td>2011</td>\n",
       "      <td>Gastrointestinal (Colorectal) Cancer</td>\n",
       "      <td>Impact of preoperative radiation dose escalati...</td>\n",
       "      <td>C. B. Patel</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; Compared with postoperat...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>48678 rows × 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       Year                                   AbstractCategory  \\\n",
       "0      1995                                        Lung Cancer   \n",
       "1      1995                                      Breast Cancer   \n",
       "2      1995                                 Gynecologic Cancer   \n",
       "3      1995                                        Lung Cancer   \n",
       "4      1995                      Other Gastrointestinal Cancer   \n",
       "5      1995                                      Breast Cancer   \n",
       "6      1995                               Genitourinary Cancer   \n",
       "7      1995      Preclinical Experimental Therapeutics - Other   \n",
       "8      1995                                      Tumor Biology   \n",
       "9      1995  Developmental TherapeuticsÑClinical Pharmacolo...   \n",
       "10     1995  Hematologic MalignanciesÑLymphoma and Chronic ...   \n",
       "11     1995  Hematologic MalignanciesÑLymphoma and Chronic ...   \n",
       "12     1995                                      Breast Cancer   \n",
       "13     1995  Hematologic MalignanciesÑLeukemia, Myelodyspla...   \n",
       "14     1995  Hematologic MalignanciesÑLeukemia, Myelodyspla...   \n",
       "15     1995  Developmental TherapeuticsÑClinical Pharmacolo...   \n",
       "16     1995                                      Breast Cancer   \n",
       "17     1995                                      Breast Cancer   \n",
       "18     1995                      Central Nervous System Tumors   \n",
       "19     1995                      Other Gastrointestinal Cancer   \n",
       "20     1995  Developmental TherapeuticsÑClinical Pharmacolo...   \n",
       "21     1995                      Other Gastrointestinal Cancer   \n",
       "22     1995                                      Breast Cancer   \n",
       "23     1995                                      Breast Cancer   \n",
       "24     1995  Developmental TherapeuticsÑClinical Pharmacolo...   \n",
       "25     1995                                            Sarcoma   \n",
       "26     1995                                      Breast Cancer   \n",
       "27     1995  Developmental TherapeuticsÑClinical Pharmacolo...   \n",
       "28     1995                     Psychosocial Aspects of Cancer   \n",
       "29     1995                               Health Care Research   \n",
       "...     ...                                                ...   \n",
       "62348  2011               Gastrointestinal (Colorectal) Cancer   \n",
       "62351  2011                           Health Services Research   \n",
       "62361  2011                          Patient and Survivor Care   \n",
       "62362  2011  Developmental TherapeuticsÑClinical Pharmacolo...   \n",
       "62371  2011  Hematologic MalignanciesÑLeukemia, Myelodyspla...   \n",
       "62386  2011  Breast CancerÑTriple-Negative/Cytotoxics/Local...   \n",
       "62396  2011               Gastrointestinal (Colorectal) Cancer   \n",
       "62402  2011  Developmental TherapeuticsÑClinical Pharmacolo...   \n",
       "62407  2011  Hematologic MalignanciesÑLymphoma and Chronic ...   \n",
       "62414  2011                               Genitourinary Cancer   \n",
       "62431  2011                     Cancer Prevention/Epidemiology   \n",
       "62452  2011                     Cancer Prevention/Epidemiology   \n",
       "62456  2011                              Melanoma/Skin Cancers   \n",
       "62462  2011                           Health Services Research   \n",
       "62467  2011                      Central Nervous System Tumors   \n",
       "62484  2011                      Central Nervous System Tumors   \n",
       "62503  2011                           Health Services Research   \n",
       "62512  2011                           Health Services Research   \n",
       "62515  2011  Developmental TherapeuticsÑExperimental Therap...   \n",
       "62541  2011                           Health Services Research   \n",
       "62543  2011                          Patient and Survivor Care   \n",
       "62544  2011                                      Tumor Biology   \n",
       "62551  2011                           Health Services Research   \n",
       "62561  2011  Developmental TherapeuticsÑExperimental Therap...   \n",
       "62564  2011                                 Pediatric Oncology   \n",
       "62568  2011  Lung Cancer - Local-Regional and Adjuvant Ther...   \n",
       "62576  2011                          Patient and Survivor Care   \n",
       "62577  2011  Developmental TherapeuticsÑExperimental Therap...   \n",
       "62585  2011                               Genitourinary Cancer   \n",
       "62604  2011               Gastrointestinal (Colorectal) Cancer   \n",
       "\n",
       "                                                   Title      FirstAuthor  \\\n",
       "0      Treatment of non-small cell lung cancer with c...  GP Stathopoulos   \n",
       "1      Treatment of primary breast cancer without mas...        A Bluming   \n",
       "2      Treatment of relapsed ovarian carcinoma with e...        M Metzner   \n",
       "3      Treatment of small cell lung cancer (SCLC) wit...    JD Hainsworth   \n",
       "4      Vaccine-based (active specific) chemoimmunothe...     SH Itzkowitz   \n",
       "5      Validation of a model that identifies high ris...         GM Clark   \n",
       "6      Validation of the PROSQOLI: a pragmatic outcom...       M Stockler   \n",
       "7      'In vitro' comparative assay on fluorouracil (...           A Abad   \n",
       "8      'Medical cultural diversity' among medical onc...        R Hochman   \n",
       "9      13-cis-retinoic acid plus low dose recombinant...        GM Turola   \n",
       "10     2-Chlorodeoxyadenosine (2-CDA) leads to partia...       T Lippuner   \n",
       "11     23-year follow-up after radiotherapy (RT) or r...       PH Wiernik   \n",
       "12     15 years follow-up for T4d (inflammatory) brea...         F Morvan   \n",
       "13     2-CDA +/- ara-C is ineffective therapy for rel...       S Kornblau   \n",
       "14     2-chlorodeoxyadenosine (2-CdA) in the treatmen...        M Tallman   \n",
       "15     3 versus 6 versus 24 hour infusions of paclita...        D Rischin   \n",
       "16     3-hr high-dose taxol (T) infusion following st...       E Mamounas   \n",
       "17     3-hr high-dose taxol (T) infusion in advanced ...       E Mamounas   \n",
       "18     3H-paclitaxel (3H-P) tissue concentrations wit...        GJ Lesser   \n",
       "19     5 fluorouracil (5Fu), mitomycin-C, leucovorin ...         GS Soori   \n",
       "20     5-Ethynyluracil (776C85), an inhibitor of dihy...         AA Adjei   \n",
       "21     5-fluorouracil (5FU) + levamisole (LEVA) vs 5F...         P Bruzzi   \n",
       "22     5-Year results of high-dose sequential (HDS) a...        AM Gianni   \n",
       "23     96-hour paclitaxel after prior short taxane in...       AD Seidman   \n",
       "24     96-hour paclitaxel without and with R-verapami...       D Riseberg   \n",
       "25     A Canadian national tumor bank/data base for s...       V Bramwell   \n",
       "26     A Canadian perspective on breast conservative ...        C Kotwall   \n",
       "27     A clinical evaluation of Duragesic (transderma...    J Gardner-Nix   \n",
       "28     A comparison of two quality-of-life (QOL) ques...          MT King   \n",
       "29     A comprehensive analysis of the cost basis of ...          F Khuri   \n",
       "...                                                  ...              ...   \n",
       "62348  Bevacizumab plus capecitabine as maintenance t...        S. Yalcin   \n",
       "62351  The relationship between cost, quality, and ou...    M. J. Hassett   \n",
       "62361  Effect of Medical Qigong on cognitive function...            B. Oh   \n",
       "62362  Tumor-targeted cancer vaccination (GeneVieve P...    J. G. Ignacio   \n",
       "62371  Activity and tolerability of the Bruton&#39;s ...       J. C. Byrd   \n",
       "62386  Lymphocyte infiltration (LI) and immunohistoch...        C. S. Yau   \n",
       "62396  Role of routine adjuvant chemotherapy after ne...      R. P. Kiran   \n",
       "62402  A novel approach to rituximab biosimilar drug ...      S. M. Berry   \n",
       "62407  Long-term safety of lenalidomide (LEN) in rela...      B. G. Durie   \n",
       "62414  Multisolution variance-based optimization (MVB...    M. A. Laviraj   \n",
       "62431  The impact of screening mammography in breast ...        C. Checka   \n",
       "62452  Body mass index: A potential risk factor for b...        V. Sharma   \n",
       "62456  Frequency of mutations associated with targete...         S. Cheng   \n",
       "62462  Rapid improvement in evidence-based, quality c...       M. A. Amin   \n",
       "62467  FLT-PET analysis of early response to everolim...   J. N. Sarkaria   \n",
       "62484  Prognostic factors in elderly patients with gr...         A. Satra   \n",
       "62503  Changes in global patterns of care for first-l...    A. J. Combest   \n",
       "62512  Time to publication of the results of clinical...      H. Katayama   \n",
       "62515  Treatment (Tx) guidelines for skin and mucosal...      M. J. Borad   \n",
       "62541  Barriers to implementing primary HER2 FISH tes...  G. J. Tsongalis   \n",
       "62543  Understanding causes for distress among cancer...     S. A. Taylor   \n",
       "62544  Fluorodeoxiglucose (FDG)-avidity at positron e...        S. Redana   \n",
       "62551  Impact of travel distance on early diagnosis o...     J. A. Holmes   \n",
       "62561  Poly(ADP ribose) polymerase (PARP) inhibition ...  D. R. Shalinsky   \n",
       "62564  A phase I study of ifosfamide, oxaliplatin, an...   L. M. McGregor   \n",
       "62568  Management of thymic epithelial tumors (TETs) ...         A. Rajan   \n",
       "62576  Spinal or epidural analgesia for cancer pain: ...         N. Yarom   \n",
       "62577  Comparative PARP enzyme inhibition of PF-01367...       K. A. Kern   \n",
       "62585  Risk stratification and stage migration effect...      B. B. Desai   \n",
       "62604  Impact of preoperative radiation dose escalati...      C. B. Patel   \n",
       "\n",
       "                                                    Body AbstractPublicationID  \n",
       "0      Cisplatin compound is established as the main ...                  1181  \n",
       "1      Between March 24, 1977, and March 24, 1983, 15...                   270  \n",
       "2      ECF has established activity and a high respon...                   784  \n",
       "3      In 7/93, we began investigation of a three-dru...                  1197  \n",
       "4      Active specific immunotherapy (ASI) is the adm...                   549  \n",
       "5      Breast cancer patients with 10 or more positiv...                    69  \n",
       "6      Rationale: Traditional outcome measures are un...                   649  \n",
       "7      The clinical experience with biochemical modul...                  1609  \n",
       "8      Most MO rely on prospective randomized trials....                  1633  \n",
       "9      Both interferons and retinoids are known to po...                   709  \n",
       "10     The prognosis of AILD, a rare low grade T-cell...                  1273  \n",
       "11     75 patients (pts) with HD pathologic stages IA...                  1285  \n",
       "12     From 1979 to 1984, 71 patients with UICC T4d i...                   265  \n",
       "13     Santana et al reported a CR rate of 8/17 (95% ...                  1005  \n",
       "14     Since human monocyte cell lines show in vitro ...                  1022  \n",
       "15     The infusion duration of paclitaxel has varied...                  1500  \n",
       "16     T has shown significant antitumor activity in ...                   207  \n",
       "17     High-dose T has shown significant antitumor ac...                   206  \n",
       "18     Ongoing clinical trials are evaluating the eff...                   292  \n",
       "19     Between 1991 and 1994, 28 patients with gastro...                   575  \n",
       "20     The erratic bioavailability (BA) of oral 5-FU ...                  1478  \n",
       "21     To determine whether the addition of 6-S-LV to...                   497  \n",
       "22     To improve the results of adjuvant chemotherap...                    61  \n",
       "23     Paclitaxel (P) via 96 hr infusion has signific...                   151  \n",
       "24     We conducted a two part trial of 96-hr infusio...                   403  \n",
       "25     A network established by a cooperative clinica...                  1694  \n",
       "26     Between 5/88 and 6/93, 220 consecutive women w...                   249  \n",
       "27     Between May 1992 and April 1994, 250 patients ...                   390  \n",
       "28     FLIC and QLQ-C30 were administered concurrentl...                  1651  \n",
       "29     We have carried out a comprehensive database a...                   905  \n",
       "...                                                  ...                   ...  \n",
       "62348  <p><b>Background:</b> Colorectal cancer is one...                   NaN  \n",
       "62351  <p><b>Background:</b> Breast cancer (BrCa) is ...                   NaN  \n",
       "62361  <p><b>Background: </b>   Cancer patients often...                   NaN  \n",
       "62362  <p><b>Background:</b> Rexin-G and Reximmune-C ...                   NaN  \n",
       "62371  <p><b>Background: </b>  Btk is essential to B-...                   NaN  \n",
       "62386  <p><b>Background:</b> IHC is a readily availab...                   NaN  \n",
       "62396  <p><b>Background:</b> The current standard of ...                   NaN  \n",
       "62402  <p><b>Background:</b>  Regulatory uncertainty ...                   NaN  \n",
       "62407  <p><b>Background:</b> LEN has significantly ex...                   NaN  \n",
       "62414  <p><b>Background:</b> Oncentra Prostate real-t...                   NaN  \n",
       "62431  <p><b>Background:</b> Recent recommendations b...                   NaN  \n",
       "62452  <p><b>Background:</b> Breast cancer (BC), the ...                   NaN  \n",
       "62456  <p><b>Background:</b> <i>BRAF</i>,<i> RAS</i>,...                   NaN  \n",
       "62462  <p><b>Background:</b> ASCO&#39;s Quality Oncol...                   NaN  \n",
       "62467  <p><b>Background:</b> 18F-fluorodeoxyuridine (...                   NaN  \n",
       "62484  <p><b>Background:</b> Anaplastic astrocytoma (...                   NaN  \n",
       "62503  <p><b>Background:</b> Few reports have focused...                   NaN  \n",
       "62512  <p><b>Background:</b> It was previously report...                   NaN  \n",
       "62515  <p><b>Background:</b> TH&#8209;302 is essentia...                   NaN  \n",
       "62541  <p><b>Background:</b> Two HER2/neu testing pro...                   NaN  \n",
       "62543  <p><b>Background:</b> While both cancer diagno...                   NaN  \n",
       "62544  <p><b>Background:</b> Reduced FDG avidity in m...                   NaN  \n",
       "62551  <p><b>Background:</b> Patients with an elevate...                   NaN  \n",
       "62561  <p><b>Background:</b> PARP activity in PBLs or...                   NaN  \n",
       "62564  <p> <b>Background:</b> Carboplatin and cisplat...                   NaN  \n",
       "62568  <p><b>Background: </b> TETs are very rare ante...                   NaN  \n",
       "62576  <p><b>Background:</b> Cancer pain is occasiona...                   NaN  \n",
       "62577  <p><b>Background:</b> Within the past several ...                   NaN  \n",
       "62585  <p><b>Background:</b> To evaluate the diagnost...                   NaN  \n",
       "62604  <p><b>Background:</b> Compared with postoperat...                   NaN  \n",
       "\n",
       "[48678 rows x 6 columns]"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ascoDF"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Prepare for wor2vec"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "ascoDF['tokenized_sents'] = ascoDF['Body'].apply(lambda x: [nltk.word_tokenize(s) for s in nltk.sent_tokenize(x)])\n",
    "ascoDF['normalized_sents'] = ascoDF['tokenized_sents'].apply(lambda x: [lucem_illud.normalizeTokens(s, stopwordLst = lucem_illud.stop_words_basic) for s in x])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We will be creating many embeddings so we have created this function to do most of the work. It creates two collections of embeddings, one the original and one the aligned."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "def compareModels(df, category, sort = True):\n",
    "    \"\"\"If you are using time as your category sorting is important\"\"\"\n",
    "    embeddings_raw = {}\n",
    "    cats = sorted(set(df[category]))\n",
    "    for cat in cats:\n",
    "        #This can take a while\n",
    "        print(\"Embedding {}\".format(cat), end = '\\r')\n",
    "        subsetDF = df[df[category] == cat]\n",
    "        #You might want to change the W2V parameters\n",
    "        embeddings_raw[cat] = gensim.models.word2vec.Word2Vec(subsetDF['normalized_sents'].sum())\n",
    "    #These are much quicker\n",
    "    embeddings_aligned = {}\n",
    "    for catOuter in cats:\n",
    "        embeddings_aligned[catOuter] = [embeddings_raw[catOuter]]\n",
    "        for catInner in cats:\n",
    "            embeddings_aligned[catOuter].append(smart_procrustes_align_gensim(embeddings_aligned[catOuter][-1], embeddings_raw[catInner]))\n",
    "    return embeddings_raw, embeddings_aligned"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Now we generate the models"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'ascoDF' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "\u001b[0;32m<ipython-input-3-f351b051e9a9>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m()\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0mrawEmbeddings\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mcomparedEmbeddings\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mcompareModels\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mascoDF\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m'Year'\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[0;31mNameError\u001b[0m: name 'ascoDF' is not defined"
     ]
    }
   ],
   "source": [
    "rawEmbeddings, comparedEmbeddings = compareModels(ascoDF, 'Year')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We need to compare them across all permutions so we will define another function to help, we will be using 1 - cosine similarity as that gives a more intitive range of 0-2 with low values meaning little change and high meaning lots of change"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "def getDivergenceDF(word, embeddingsDict):\n",
    "    dists = []\n",
    "    cats = sorted(set(embeddingsDict.keys()))\n",
    "    dists = {}\n",
    "    for cat in cats:\n",
    "        dists[cat] = []\n",
    "        for embed in embeddingsDict[cat][1:]:\n",
    "            dists[cat].append(np.abs(1 - sklearn.metrics.pairwise.cosine_similarity(np.expand_dims(embeddingsDict[cat][0][word], axis = 0),\n",
    "                                                                             np.expand_dims(embed[word], axis = 0))[0,0]))\n",
    "    return pandas.DataFrame(dists, index = cats)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Lets look at a couple words"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "targetWord = 'breast'\n",
    "\n",
    "pltDF = getDivergenceDF(targetWord, comparedEmbeddings)\n",
    "fig, ax = plt.subplots(figsize = (10, 7))\n",
    "seaborn.heatmap(pltDF, ax = ax, annot = False) #set annot True for a lot more information\n",
    "ax.set_xlabel(\"Starting year\")\n",
    "ax.set_ylabel(\"Final year\")\n",
    "ax.set_ylabel(\"Final year\")\n",
    "ax.set_title(\"Yearly linguistic change for: '{}'\".format(targetWord))\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "targetWord = 'triple'\n",
    "\n",
    "pltDF = getDivergenceDF(targetWord, comparedEmbeddings)\n",
    "fig, ax = plt.subplots(figsize = (10, 7))\n",
    "seaborn.heatmap(pltDF, ax = ax, annot = False) #set annot True for a lot more information\n",
    "ax.set_xlabel(\"Starting year\")\n",
    "ax.set_ylabel(\"Final year\")\n",
    "ax.set_ylabel(\"Final year\")\n",
    "ax.set_title(\"Yearly linguistic change for: '{}'\".format(targetWord))\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We can also ask which words changed the most"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "def findDiverence(word, embeddingsDict):\n",
    "    cats = sorted(set(embeddingsDict.keys()))\n",
    "    \n",
    "    dists = []\n",
    "    for embed in embeddingsDict[cats[0]][1:]:\n",
    "        dists.append(1 - sklearn.metrics.pairwise.cosine_similarity(np.expand_dims(embeddingsDict[cats[0]][0][word], axis = 0), np.expand_dims(embed[word], axis = 0))[0,0])\n",
    "    return sum(dists)\n",
    "\n",
    "def findMostDivergent(embeddingsDict):\n",
    "    words = []\n",
    "    for embeds in embeddingsDict.values():\n",
    "        for embed in embeds:\n",
    "            words += list(embed.wv.vocab.keys())\n",
    "    words = set(words)\n",
    "    print(\"Found {} words to compare\".format(len(words)))\n",
    "    return sorted([(w, findDiverence(w, embeddingsDict)) for w in words], key = lambda x: x[1], reverse=True)\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "wordDivergences = findMostDivergent(comparedEmbeddings)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The most divergent words are:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "wordDivergences[:10]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "And the least"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "wordDivergences[-10:]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "targetWord = wordDivergences[0][0]\n",
    "\n",
    "pltDF = getDivergenceDF(targetWord, comparedEmbeddings)\n",
    "fig, ax = plt.subplots(figsize = (10, 7))\n",
    "seaborn.heatmap(pltDF, ax = ax, annot = False) #set annot True for a lot more information\n",
    "ax.set_xlabel(\"Starting year\")\n",
    "ax.set_ylabel(\"Final year\")\n",
    "ax.set_ylabel(\"Final year\")\n",
    "ax.set_title(\"Yearly linguistic change for: '{}'\".format(targetWord))\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "targetWord = wordDivergences[-1][0]\n",
    "\n",
    "pltDF = getDivergenceDF(targetWord, comparedEmbeddings)\n",
    "fig, ax = plt.subplots(figsize = (10, 7))\n",
    "seaborn.heatmap(pltDF, ax = ax, annot = False) #set annot True for a lot more information\n",
    "ax.set_xlabel(\"Starting year\")\n",
    "ax.set_ylabel(\"Final year\")\n",
    "ax.set_ylabel(\"Final year\")\n",
    "ax.set_title(\"Yearly linguistic change for: '{}'\".format(targetWord))\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## <span style=\"color:red\">*Exercise 1b*</span>\n",
    "\n",
    "<span style=\"color:red\">**Do only 3a or 3b.** Construct cells immediately below this that align word embeddings over time. Interrogate the spaces that result and ask which words change most of the whole period. What does this reveal about the social game underlying your space?"
   ]
  }
 ],
 "metadata": {
  "anaconda-cloud": {},
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 1
}
